According to the UnivDatos Market Insights, the surge in chronic disease cases like cancer and macular degeneration and the rise in research and development activities will drive the global scenario of the Bispecific antibody market and as per their “Bispecific Antibody Market” report, the global market was valued at USD 7.8 Billion in 2022, growing at a CAGR of about 11.2% during...

According to a new report by UnivDatos Market Insights, Bispecific Antibody Market is expected to reach USD XX Billion in 2030 by growing at a CAGR of ~11.2%. Bispecific antibodies (bsAbs) are a class of therapeutic proteins designed to simultaneously bind to two different antigens or epitopes. They are engineered to possess dual specificity, allowing them to target two distinct molecules or...